- Home
- AQST vs PBAM Comparison
AQST vs PBAM Comparison
Compare AQST & PBAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.70
Company Overview
Basic Information| Metric | AQST | PBAM |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 479.5M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | AQST | PBAM |
|---|---|---|
| Price | $3.70 | N/A |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | N/A |
| Earning Date | 05-01-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $10.08 | N/A |
| Revenue Next Year | $49.60 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.94 | N/A |
| 52 Week High | $7.55 | N/A |
Technical Indicators
Market Signals| Indicator | AQST | PBAM |
|---|---|---|
| Relative Strength Index (RSI) | 37.30 | N/A |
| Support Level | $3.16 | N/A |
| Resistance Level | $4.35 | N/A |
| Average True Range (ATR) | 0.20 | 0.00 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 18.55 | 0.00 |
Price Performance
Historical Comparison AQST
PBAM
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.